Pricing Log in Create free account

Incannex Healthcare Inc. (IXHL) vs Zhengye Biotechnology Holding Limited (ZYBT)

Incannex Healthcare Inc. and Zhengye Biotechnology Holding Limited are both Drug Manufacturers Specialty & Generic companies. Zhengye Biotechnology Holding Limited is the larger, with a market value of $41.0M against $28.5M — 1.4× the size. Across the 7 metrics below, Zhengye Biotechnology Holding Limited leads on 4 and Incannex Healthcare Inc. on 3.

Valuation

Metric IXHL ZYBT Drug Manufacturers Specialty & Generic median
P/E n/m — 20.55
P/S 16.88 — 2.08
P/B 0.39 n/m 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA 1.65 n/m 12.22
EV/Sales (24.08) n/m 2.87
Earnings yield (75.75%) — (15.94%)
Free cash flow yield (48.87%) 0.00% 0.00%

Profitability

Metric IXHL ZYBT Drug Manufacturers Specialty & Generic median
Gross margin (0.10%) — 53.51%
Operating margin 0.00% — 0.00%
Net margin 0.00% — (2.45%)
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (47.80%) 0.00% (0.80%)
Return on assets (41.32%) 0.00% (1.67%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IXHL ZYBT Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — — 5.22%
EPS growth (last fiscal year) 95.91% (800.00%) 42.91%
Revenue growth, 5-year CAGR (29.64%) — 7.24%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric IXHL ZYBT Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.24 0.04
Current ratio 48.81 1.14 2.41
Net debt to EBITDA 2.97 (0.51) 1.01

Dividend

Metric IXHL ZYBT Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric IXHL ZYBT Drug Manufacturers Specialty & Generic median
Market cap 28.47m 41.02m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack